Detalhe da pesquisa
1.
Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO study.
Br J Haematol
; 204(5): 2049-2056, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38343073
2.
Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy.
Br J Haematol
; 196(2): 368-373, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34490623
3.
Updated results of the placebo-controlled, phase III JAKARTA trial of fedratinib in patients with intermediate-2 or high-risk myelofibrosis.
Br J Haematol
; 195(2): 244-248, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331348
4.
Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.
Br J Haematol
; 192(1): 62-74, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32449159
5.
A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK.
Br J Haematol
; 188(6): e105-e109, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32077091
6.
Assessing Landscape Change and Processes of Recurrence, Replacement, and Recovery in the Southeastern Coastal Plains, USA.
Environ Manage
; 56(5): 1252-71, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26163198
7.
Autologous 111 In-labelled platelet scan as a predictor of splenectomy outcome in ITP.
Br J Haematol
; 184(6): 1043-1045, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29676450
8.
Changes in landscape and climate in Mexico and Texas reveal small effects on migratory habitat of monarch butterflies (Danaus plexippus).
Sci Rep
; 14(1): 6703, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509089
9.
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis.
Nat Commun
; 14(1): 7725, 2023 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001082
10.
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial.
J Clin Oncol
; 41(19): 3534-3544, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126762
11.
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.
Nat Genet
; 55(9): 1531-1541, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666991
12.
Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UK.
EJHaem
; 3(3): 785-793, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36051073
13.
Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series.
Haematologica
; 101(5): e182-4, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26819057
14.
Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.
Haematologica
; 101(5): e185-8, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26869629
15.
Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses.
J Clin Oncol
; 39(8): 890-901, 2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356418
16.
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial.
Nat Med
; 27(12): 2183-2191, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34873347
17.
Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b studyâ.
Leuk Res
; 100: 106489, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33302031
18.
Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
Haematologica
; 95(2): 224-31, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19833633
19.
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib.
PLoS Comput Biol
; 5(9): e1000503, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19749982
20.
Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia.
Br J Haematol
; 167(3): 421-3, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24935860